Equillium, Inc.
NASDAQ Global MarketTotal Valuation
Equillium, Inc. carries a market capitalization of 78.63M, placing it among publicly traded companies globally. Its enterprise value stands at 146.33M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 78.63M |
| Enterprise Value | 146.33M |
Share Statistics
Equillium, Inc. currently has 63.41M shares outstanding.
| Shares Outstanding | 63.41M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 3.62 |
| P/TBV Ratio | 3.62 |
| P/FCF Ratio | -14.72 |
| P/OCF Ratio | -14.63 |
Financial Position
Equillium, Inc. maintains a current ratio of 23.40, meaning it holds 23.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 23.40 |
| Quick Ratio | 23.07 |
| Debt / Equity | 1.04 |
| Debt / EBITDA | -0.03 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -58.98 |
| Return on Assets (ROA) | -50.68 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Equillium, Inc.'s stock has declined approximately -15.06849% over the past 52 weeks. The 50-day moving average sits at 1.93, while the 200-day moving average is 2.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | -15.06849% |
| 50-Day Moving Average | 1.93 |
| 200-Day Moving Average | 2.07 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -19.20M, while operating income came in at -19.30M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -19.30M |
| Pretax Income | -18.01M |
| Net Income | -18.01M |
| EBITDA | -19.20M |
| EBIT | -19.30M |
| Earnings Per Share (EPS) | -0.20 |
Balance Sheet
Equillium, Inc. holds 57.16M in cash and equivalents against 584,000.00 in total debt, resulting in a net debt position of -57.16M. Total book value stands at 56.02M, with working capital of 55.50M providing operational flexibility.
| Cash & Cash Equivalents | 57.16M |
| Total Debt | 584,000.00 |
| Net Debt | -57.16M |
| Equity (Book Value) | 56.02M |
| Book Value Per Share | 0.88 |
| Working Capital | 55.50M |
Cash Flow
Equillium, Inc. produced -19.97M in operating cash flow over the past twelve months. After subtracting -118,000.00 in capital expenditures, free cash flow totaled -20.09M - equivalent to -0.22 per share.
| Operating Cash Flow | -19.97M |
| Capital Expenditures | -118,000.00 |
| Free Cash Flow | -20.09M |
| FCF Per Share | -0.22 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -32.40 |
| FCF Yield | -6.79 |
Scores
Equillium, Inc. posts an Altman Z-Score of 40.59, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 40.59 |